Parallel Session: Hepatitis B: Therapeutics (New)

Watch this live session to see some the top research in Hepatitis B. Content will only be aired on this date, at this time. Don't miss it!

• Novel HLA-E Specific IMMTAV® Molecules for the Treatment of Hepatitis B
  Presenting Author Sarah Leonard
• HBsAg Reduction by Nasal Administration of a Therapeutic Vaccine Containing HBsAG and HBCAG (NASVAC) in Patients with Chronic HBV Infection: The Results of 18 Months Follow Up
  Presenting Author Osamu Yoshida
• Targeting Hbx by CRISPR/Cas9 System effectively Reduces the EMT and STEMNESS Characteristics of HCC Cells In Vitro
  Presenting Author Preety Rawal
• Novel Anti-HBV Therapies Using CRISPR/Cas9 Targeting HBV Genome Strongly Suppress HBV
  Presenting Author Kazuhiro Murai
• Safety and Pharmacodynamics of the Galnac-siRNA AB-729 in Subjects with Chronic Hepatitis B Infection
  Presenting Author Man-Fung Yuen
• Combination of Antisense Oligonucleotides (ASOS) ALG -020572 and ALG-020576 Against Hepatitis B Virus (HBV) Improves Activity and can be Combined with Other Anti-HBV Agents
  Presenting Author Jin Hong